Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception

In recent years, there has been a significant increase in the practice of regenerative medicine by health practitioners and direct-to-consumer businesses globally. Among different tools of regenerative medicine, platelet-rich plasma (PRP) and stem cell-based therapies have received considerable atte...

Full description

Saved in:
Bibliographic Details
Main Authors: Fareez, Ismail M., Liew, Fong Fong, Widera, Darius, Mayeen, Naiyareen Fareeza, Mawya, Jannatul, Abu Kasim, Noor Hayaty, Haque, Nazmul
Format: Article
Published: Bentham Science Publishers 2024
Subjects:
Online Access:http://eprints.um.edu.my/47081/
https://doi.org/10.2174/1566524023666230511152646
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.um.eprints.47081
record_format eprints
spelling my.um.eprints.470812024-11-22T04:01:01Z http://eprints.um.edu.my/47081/ Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception Fareez, Ismail M. Liew, Fong Fong Widera, Darius Mayeen, Naiyareen Fareeza Mawya, Jannatul Abu Kasim, Noor Hayaty Haque, Nazmul QH Natural history R Medicine (General) In recent years, there has been a significant increase in the practice of regenerative medicine by health practitioners and direct-to-consumer businesses globally. Among different tools of regenerative medicine, platelet-rich plasma (PRP) and stem cell-based therapies have received considerable attention. The use of PRP, in particular, has gained popularity due to its easy access, simple processing techniques, and regenerative potential. However, it is important to address a common misconception amongst the general public equating to PRP and stem cells due to the demonstrated efficacy of PRP in treating musculoskeletal and dermatological disorders. Notably, PRP promotes regeneration by providing growth factors or other paracrine factors only. Therefore, it cannot replenish or replace the lost cells in conditions where a large number of cells are required to regenerate tissues and/or organs. In such cases, cell-based therapies are the preferred option. Additionally, other tools of regenerative medicine, such as bioprinting, organoids, and mechanobiology also rely on stem cells for their success. Hence, healthcare and commercial entities offering direct-to-customer regenerative therapies should not mislead the public by claiming that the application of PRP is a stem cell-based therapy. Furthermore, it is important for regulatory bodies to strictly monitor these profit-driven entities to prevent them from providing unregulated regenerative treatments and services that claim a broad variety of benefits with little proof of efficacy, safety concerns, and obscure scientific justification. Bentham Science Publishers 2024 Article PeerReviewed Fareez, Ismail M. and Liew, Fong Fong and Widera, Darius and Mayeen, Naiyareen Fareeza and Mawya, Jannatul and Abu Kasim, Noor Hayaty and Haque, Nazmul (2024) Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception. Current Molecular Medicine, 24 (6). pp. 689-701. ISSN 1566-5240, DOI https://doi.org/10.2174/1566524023666230511152646 <https://doi.org/10.2174/1566524023666230511152646>. https://doi.org/10.2174/1566524023666230511152646 10.2174/1566524023666230511152646
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic QH Natural history
R Medicine (General)
spellingShingle QH Natural history
R Medicine (General)
Fareez, Ismail M.
Liew, Fong Fong
Widera, Darius
Mayeen, Naiyareen Fareeza
Mawya, Jannatul
Abu Kasim, Noor Hayaty
Haque, Nazmul
Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception
description In recent years, there has been a significant increase in the practice of regenerative medicine by health practitioners and direct-to-consumer businesses globally. Among different tools of regenerative medicine, platelet-rich plasma (PRP) and stem cell-based therapies have received considerable attention. The use of PRP, in particular, has gained popularity due to its easy access, simple processing techniques, and regenerative potential. However, it is important to address a common misconception amongst the general public equating to PRP and stem cells due to the demonstrated efficacy of PRP in treating musculoskeletal and dermatological disorders. Notably, PRP promotes regeneration by providing growth factors or other paracrine factors only. Therefore, it cannot replenish or replace the lost cells in conditions where a large number of cells are required to regenerate tissues and/or organs. In such cases, cell-based therapies are the preferred option. Additionally, other tools of regenerative medicine, such as bioprinting, organoids, and mechanobiology also rely on stem cells for their success. Hence, healthcare and commercial entities offering direct-to-customer regenerative therapies should not mislead the public by claiming that the application of PRP is a stem cell-based therapy. Furthermore, it is important for regulatory bodies to strictly monitor these profit-driven entities to prevent them from providing unregulated regenerative treatments and services that claim a broad variety of benefits with little proof of efficacy, safety concerns, and obscure scientific justification.
format Article
author Fareez, Ismail M.
Liew, Fong Fong
Widera, Darius
Mayeen, Naiyareen Fareeza
Mawya, Jannatul
Abu Kasim, Noor Hayaty
Haque, Nazmul
author_facet Fareez, Ismail M.
Liew, Fong Fong
Widera, Darius
Mayeen, Naiyareen Fareeza
Mawya, Jannatul
Abu Kasim, Noor Hayaty
Haque, Nazmul
author_sort Fareez, Ismail M.
title Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception
title_short Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception
title_full Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception
title_fullStr Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception
title_full_unstemmed Application of Platelet-Rich Plasma as a Stem Cell Treatment - an Attempt to Clarify a Common Public Misconception
title_sort application of platelet-rich plasma as a stem cell treatment - an attempt to clarify a common public misconception
publisher Bentham Science Publishers
publishDate 2024
url http://eprints.um.edu.my/47081/
https://doi.org/10.2174/1566524023666230511152646
_version_ 1817841972608499712
score 13.223943